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AMP-activated protein kinase (AMPK) is a nutrient-sensitive kinase that can be regulated by Ca2+-elevating 
agents that activate upstream kinases and by various cellular 
stresses including hypoxia.1 In endothelial cells, the AMPK is 
required for an adequate angiogenic response to hypoxia2 and 
can induce the generation of vascular endothelial growth fac-
tor (VEGF).3 Angiogenesis and vascular repair after ischemia 
in vivo also rely on the recruitment and activation of circulat-
ing cells such as monocytes and neutrophils.4 Little is known 
about the role of the AMPK in such processes, but the kinase 
has been implicated in inflammatory signaling in myeloid 
cells,5 such as leukocyte homing and neutrophil activation,6 
and monocyte differentiation.7–9
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The AMPK is a heterotrimeric kinase consisting of a cata-
lytic α subunit and regulatory β and γ subunits. There are 2 
different isoforms of the catalytic α subunit, that is, the α1 sub-
unit that is mainly localized to the cytosol and the α2 subunit 
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that can translocate to the nucleus, where it likely plays a 
more important role in transcription factor activation and gene 
regulation.1 Although many studies have reported a role for 
AMPK activation in angiogenesis in vitro and in vivo, they 
generally relied on unspecific pharmacological tools that can-
not differentiate between the different catalytic α subunits. We 
reported previously that the AMPKα1 subunit in endothelial 
cells is a prerequisite for angiogenesis induced by cytokines 
and VEGF via a mechanism involving transforming growth 
factor-β–activated kinase 1 and superoxide dismutase 2 ex-
pression.10 The aim of the present study was to assess the role 
of AMPK, particularly the AMPKα2 subunit, in the regulation 
of vascular repair in vivo in a model where the outcome is 
largely dependent on local responses to hypoxia and the mo-
bilization and recruitment of bone marrow–derived cells such 
as monocytes and neutrophils.
Methods
Animals
C57BL/6J mice were purchased from Charles River (Sulzfeld, 
Germany).
Genetically modified mice lacking either the AMPKα1 or the 
AMPKα2 subunits, their respective wild-type littermates, and floxed 
AMPKα2 mice were kindly provided by Benoit Viollet (INSERM, 
U1016, Paris, France) and bred at the Goethe University Hospital 
animal facility. Floxed AMPKα2 mice were crossed with animals 
expressing the Cre-deleter under the control of the Tie-2 promoter 
(B6.Cg-Tg(Tek-cre)12Flv/J; Jackson Laboratories, Bar Harbor, ME) 
to generate mice lacking the α2 subunit in endothelial cells and some 
myeloid cells (Tie2-α2), with VE-cadherin-Cre mice (B6-Tg(Cdh5-
cre)/J; Polygene, Switzerland) to generate animals mice lack-
ing the α2 subunit specifically in endothelial cells (AMPKα2ΔEC), 
or with LysM-Cre mice (B6.129P2-Lyz2tm1(cre)Ifo/J; Jackson 
Laboratories) to generate mice lacking the α2 subunit specifically in 
myeloid cells (AMPKα2ΔMC).
All animals were housed in conditions that conform to the Guide 
for the Care and Use of Laboratory Animals published by the US 
National Institutes of Health (NIH publication No. 85-23). Both the 
University Animal Care Committee and the Federal Authority for 
Animal Research at the Regierungspräsidium Darmstadt (Hessen, 
Germany) approved the study protocol (#F28/25). For the isolation of 
organs, mice were euthanized using 4% isoflurane in air and subse-
quent exsanguination or decapitation.
Hindlimb Ischemia
Arteriogenic and angiogenic capacity was investigated in a murine 
model of hindlimb ischemia using 6- to 8-week-old wild-type and 
transgenic animals as described.11
Statistical Analysis
Data are expressed as mean±SEM. Statistical evaluation was per-
formed using Student t test for unpaired data, 1-way ANOVA followed 
by a Bonferroni t test, or ANOVA for repeated measures where ap-
propriate. Values of P<0.05 were considered statistically significant.
Reagents and other detailed methods are described in the Online 
Data Supplement.
Results
Effects of AMPKα2 Deletion on Vascular Repair
Diabetes mellitus is not only a risk factor for the develop-
ment of cardiovascular disease but is linked with impaired 
vascular repair after injury and ischemia.12,13 Given that the 
AMPKα2 subunit was reported to be a regulator of whole 
body insulin sensitivity,14 vascular repair after femoral artery 
ligation was assessed in wild-type and AMPKα2−/− mice. The 
recovery of blood flow in ischemic hindlimbs was markedly 
attenuated in AMPKα2−/− mice compared with their wild-
type littermates over 14 days (Figure 1A). The restoration of 
hindlimb perfusion is dependent on arteriogenesis and angio-
genesis, and micro computed tomography analyses revealed 
a clearly impaired arteriogenesis, defined as the development 
of remodeled collaterals with a corkscrew morphology, in the 
AMPKα2−/− mice (Figure 1B). The delayed functional recov-
ery was also reflected in the decreased capillary density in the 
calf muscles 14 days after surgery (Figure 1C).
AMPKα2 in Endothelial Versus Myeloid Cells
Arteriogenesis and angiogenesis are determined by endothelial 
cells and circulating cells.4 To determine whether the reduced 
recovery after hindlimb ischemia was dependent on the dele-
tion of AMPKα2 in endothelial cells or other cell types, experi-
ments were repeated in AMPKα2flox/flox mice crossed with mice 
expressing the Cre-deleter under the control of the Tie-2 pro-
moter (Tie2-α2 mice) and their wild-type littermates. Although 
there was delayed recovery of perfusion in the Tie2-α2 versus 
wild-type mice (Figure 2A), the effect was much less impres-
sive than that in the global knockout animals. Although the 
Tie-2 promoter is frequently used to target endothelial cells, 
it is also expressed by a subset of myeloid cells.15,16 Therefore, 
endothelial cells were more specifically targeted by crossing 
AMPKα2flox/flox mice with mice expressing the Cre-deleter un-
der the control of the VE-cadherin promoter. However, the en-
dothelial cell–specific deletion of the AMPKα2 had no effect 
on the recovery from hindlimb ischemia (Figure 2B).
As the results indicated that the AMPKα2 in mononucle-
ar cells may explain the observations, the expression of the 
AMPKα2 subunit was assessed in myeloid cells. AMPKα2 
mRNA was clearly expressed in the aorta and in peritoneal 
macrophages from wild-type mice (Figure 2C). Crossing 
AMPKα2flox/flox mice with LysM-Cre mice, to generate animals 
lacking the AMPKα2 in myeloid cells (AMPKα2ΔMC mice), 
resulted in the loss of AMPKα2 mRNA expression in macro-
phages (Figure 2C) and protein expression in CD11b+ (my-
eloid lineage) cells (Figure 2D). However, the CD11b− cell 
population from the same animals did express AMPKα2, con-
firming the specificity of the LysM-Cre–dependent deletion.
The myeloid cell–specific deletion of AMPKα2 resulted 
in a decrease in circulating neutrophils under basal conditions 
that could not be explained by altered hematopoietic stem cell 
differentiation or mobilization. The deletion of the AMPKα2 
in myeloid cells did not alter the composition of hematopoi-
etic stem cell populations or the more committed lineages 
in bone marrow from untreated mice or after treatment with 
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granulocyte colony-stimulating factor (Online Figure IA). 
Neither the proliferation nor the differentiation of mobilized 
progenitors was altered 5 days after granulocyte colony-stim-
ulating factor administration as assessed by using a colony-
forming unit assay (Online Figure IB). These findings fit with 
the reported lack of effect of AMPK deletion on normal hema-
topoietic stem cell function.17
AMPKα2ΔMC mice reproduced the phenotype of the 
AMPKα2−/− mice in that only minimal recovery of hindlimb 
blood flow was observed over 14 days after the induction 
of ischemia (Figure 2E). Fitting with the delayed recovery 
of blood flow, arteriogenesis was less pronounced in the 
AMPKα2ΔMC mice compared with their wild-type littermates. 
The latter animals developed remodeled collaterals that 
largely failed to form in the AMPKα2ΔMC mice (Figure 2F). 
Angiogenesis, assessed as the number of capillaries (CD31+ 
cells) in the semimembranosus muscle (Figure 2G) and gas-
trocnemius muscle (Figure 2H), was also markedly decreased 
in ischemic hindlimbs from AMPKα2ΔMC mice. The AMPKα1 
subunit is more highly expressed than the AMPKα2 isoform 
in myeloid cells. Despite this, the deletion of the AMPKα2 
subunit attenuated neutrophil AMPK phosphorylation on the 
activating Thr172 site (the phospho-specific antibody used 
cannot differentiate between the AMPKα1 and α2 isoforms) 
under basal conditions and in cells exposed to hypoxia (Online 
Figure IIA). To confirm the importance of the AMPKα2 iso-
form in vascular repair, we also generated a myeloid cell–
specific AMPKα1-deficient mouse. Although vascular repair 
after ischemia was attenuated in mice lacking the α1 subunit 
in myeloid cells, the effect was much less pronounced than 
that seen in AMPKα2ΔMC mice (compare Online Figure IIB 
and Figure 2E).
Altered Recruitment of Myeloid Cells to Ischemic 
Hindlimbs in AMPKα2ΔMC Mice
As the rapid recruitment of myeloid cells to the ischemic tis-
sue has been implicated in arteriogenesis and angiogenesis, 
the recruitment of the different cell populations was studied 3 
days after the induction of ischemia.
Using hematoxylin–eosin staining, distinctly fewer infiltrat-
ing cells were detected in ischemic muscles from AMPKα2ΔMC 
mice compared with their wild-type littermates (Figure 3A). In 
ischemic muscles from wild-type animals, leukocytes (CD45+ 
cells), neutrophils (Gr1+ cells), and macrophages (F4/80+ cells) 
were abundant but were significantly lower in the AMPKα2ΔMC 
group (Figure 3B). Infiltrating cells have a significant impact on 
the local environment in the ischemic skeletal muscle, and anal-
ysis of mRNA expression of a wide range of angiogenic markers 
and inflammatory chemokines and cytokines in the ischemic gas-
trocnemius muscle revealed pronounced differences (Figure 3C; 
Online Figure III). For example, levels of transforming growth 
factor (TGF)β, VEGFA and VEGFB, and the VEGF receptor 1 
(VEGFR1) and VEGFR2 were lower in ischemic muscles from 
AMPKα2ΔMC mice compared with their wild-type littermates. 
On the contrary, the expression of several inflammatory media-
tors and chemokines were upregulated in ischemic muscles from 
AMPKα2ΔMC mice including tumor necrosis factor-α, interleu-
kin (IL)-1β, and chemokine (C-C motif) ligand 2 (CCL2), also 
known as monocyte chemoattractant factor 1 (MCP-1) and its 
receptor C-C chemokine receptor type 2 (CCR2). The latter also 
coincided with endothelial cell activation as indicated by the up-
regulation of intercellular adhesion molecule-1, which was con-
firmed by immunohistochemistry (Figure 3D). This altered gene 
expression pattern was consistently observed in the gastrocne-
mius and in the semimembranosus muscles (Online Figure III).
To determine whether myeloid cell recruitment to the 
ischemic muscle or myeloid cell survival in the hypoxic en-
vironment was altered by the deletion of the AMPKα2 sub-
unit, experiments were repeated 1 day after surgery. Within 
24 hours of ischemia, leukocyte infiltration was similar in 
the ischemic hindlimbs from wild-type and AMPKα2ΔMC 
mice (Figure 4A). However, a significantly higher number 
of neutrophils were recruited to the gastrocnemius mus-
cle of AMPKα2ΔMC mice than their wild-type littermates 
Figure 1. Recovery of blood flow and 
revascularization in ischemic hindlimbs 
after femoral artery ligation in diabetic 
and AMPKα2−/− mice. A, Reperfusion 
after femoral artery ligation as measured 
by laser Doppler analysis in wild-type 
(WT) and AMPKα2−/− littermates (n=9 per 
group). B, Micro computed tomography 
angiography of ligated limbs from WT and 
AMPKα2−/− mice 7 d post surgery. Arrows 
indicate site of ligation. Similar results 
were obtained in an additional 2 animals 
in each group. C, CD31+ capillaries 
in transverse sections of ischemic 
gastrocnemius muscles from WT and 
AMPKα2−/− mice (bar=100 µm; n=4 per 
group). *P<0.05, **P<0.01, ***P<0.001 
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(Figure 4B). At this early time point, no macrophages were 
consistently detected in the ischemic muscles. In in vitro 
migration assays, neutrophils from AMPKα2ΔMC mice more 
effectively migrated through an endothelial cell monolayer 
(Figure 4C) even though directed migration toward a cy-
tokine, the murine IL-8 homologue CXCL1, did not differ 
between the 2 strains (data not shown). Confocal micros-
copy confirmed the elevated neutrophil infiltration into 
ischemic muscles from AMPKα2ΔMC mice 24 hours after 
surgery (Figure 4D). In these samples, intra- and extravas-
cular neutrophils were easier to detect in whole mounts from 
AMPKα2ΔMC mice versus their wild-type littermates, indi-
cating an improved transendothelial migration also in vivo 
(Online Figure IV). Moreover, although circulating numbers 
of neutrophils were lower under basal conditions, they were 
comparable in wild-type and AMPKα2ΔMC littermates 24 
hours after the induction of ischemia, indicating a lack of 
a defect in mobilization (Online Figure V). Taken together, 
these data point out that, compared with responses in wild-
type littermates, the response to ischemia in hindlimbs from 
AMPKα2ΔMC mice is linked to an increase in early neutrophil 
infiltration, the upregulation of inflammatory cytokines, and 
adhesion molecule expression followed by a later (72 hours) 
decline in neutrophil numbers.
AMPKα2 Regulates Neutrophil Survival Under 
Hypoxia
Circulating neutrophils are short-lived cells, but their life 
span can be prolonged under hypoxic conditions. The de-
creased recovery of neutrophils from ischemic hindlimbs 
3 days after ligation hinted at an increased apoptosis of 
AMPKα2ΔMC neutrophils. To determine which AMPKα2-
regulated proteins were altered by hypoxia, bone mar-
row–derived neutrophils were isolated from wild-type and 
Figure 2. Comparison of the 
consequences of endothelial cell 
and myeloid cell AMP-activated 
protein kinase (AMPK) α2 deletion on 
vascular repair. A and B, Recovery of 
blood flow after femoral artery ligation in 
hindlimbs from (A) wild-type (WT), Tie2-
α2 littermates (n=8 per group), and (B) 
WT and AMPKα2ΔEC littermates (n=4 per 
group). C, AMPKα2 mRNA expression in 
aorta and macrophages isolated from WT, 
AMPKα2−/− or AMPKα2ΔMC mice. Similar 
results were obtained in 2 additional 
experiments. D, AMPKα2 and AMPKα1 
protein expression in CD11b− and 
CD11b+ cells isolated from spleens from 
WT and AMPKα2ΔMC littermates. Similar 
results were obtained in 2 additional 
experiments. E, Recovery of blood flow 
after femoral artery ligation in hindlimbs 
from WT and AMPKα2ΔMC mice (n=9 per 
group). F, Micro computed tomography 
angiography of ligated limbs from WT 
and AMPKα2ΔMC mice, 7 d post surgery. 
Arrows indicate site of ligation. G and H, 
Anti-CD31 immuno-stained capillaries 
(green) in the semimembranosus (G) and 
gastrocnemius (H) muscles of ligated 
limbs from WT and AMPKα2ΔMC mice 
14 d after surgery. The quantification 
was performed relative to the nonligated 
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AMPKα2ΔMC littermates and maintained under normoxic or 
hypoxic conditions for 16 hours. Thereafter, altered protein 
expression was determined by mass spectrometry. Online 
Table I summarizes all of the proteins identified, number of 
identified peptides, accession numbers, and sequence cover-
age of each sample. The quantification of the results is sum-
marized in Online Table II.
Fitting with the in vivo observations, neutrophils from 
AMPKα2ΔMC mice expressed lower levels of the antiapop-
totic proteins: translocase of inner mitochondrial mem-
brane 50 and apoptosis inhibitor 5 (Figure 5A and 5B). 
These changes were accompanied by an increase in cas-
pase-3 cleavage and Bax expression (Figure 5C) and an in-
crease in caspase activity in neutrophils lacking AMPKα2 
(Figure 5D). Thus, the expression of the AMPKα2 in neu-
trophils is required for protection against apoptosis in hy-
poxic conditions.
AMPKα2 Regulates Hypoxia-Inducible Factor-1α 
Hydroxylation and Stabilization and Hypoxia-
Inducible Factor-1α–Dependent Responses in 
AMPKα2-Deficient Neutrophils
The most prominent difference in the proteome of neutrophils 
from the 2 strains was that the neutrophils lacking AMPKα2 
demonstrated an impaired response to hypoxia (Figure 6A; 
Online Figure VI). This finding fits with reports that myeloid 
cell function is strongly dependent on and mediated by hypox-
ia-inducible factor (HIF)-1α,18 which is crucial for prolonging 
neutrophil survival under hypoxic conditions.19
HIF-1α protein levels can be modified by several kinases,20 
and previous studies in a prostate cancer cell line indicated that 
global AMPK inhibition may attenuate hypoxia-induced re-
sponses such as HIF-1α target gene expression.21 Therefore, 
we determined whether or not AMPK can affect HIF-1α stabil-
ity in HEK293 cells, which express both the AMPKα1 and α2 
Figure 3. Myeloid cell infiltration 
into the ischemic hindlimb 72 h post 
surgery. A, Representative hematoxylin–
eosin images and quantification of 
infiltrated cells into gastrocnemius 
muscle. Bar=100 µm. The graph 
summarizes data from 5 animals per 
group. B, CD45+, Gr1+, and F4/80+ 
cells isolated from the gastrocnemius 
muscle of the ligated and nonligated 
hindlimbs from wild-type (WT) and 
AMPKα2ΔMC (ΔMC) 3 d after ligation (n=5 
per group). C, Chemokine and cytokine 
gene expression analysis in ischemic 
hindlimbs. Green bars show significantly 
(P<0.05) downregulated genes, and red 
bars indicate significantly upregulated 
genes in AMPKα2ΔMC compared with 
WT mice (n=4 animals in each group). 
D, Intercellular adhesion molecule 
(ICAM)-1 and CD31 immunostaining in 
the gastrocnemius muscle. Bar=20 µm. 
*P<0.05, **P<0.01, ***P<0.001. AMPK 
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subunits. In cells maintained under normoxic conditions, HIF-1α 
levels were not detectable, but the protein was clearly induced 
after exposure of cells to hypoxia (1% O
2
, 6 and 16 hours) or 
cobalt chloride (150 µmol/L, 6 hours; Figure 6B). Although the 
downregulation of the AMPKα1 subunit had little effect on the 
induction of HIF-1α by either stimulus, HIF-1α levels were con-
sistently lower in HEK293 cells treated with small interfering 
RNA directed against the AMPKα2 subunit. The serine phos-
phorylation of HIF-1α has been linked with its destabilization22,23; 
therefore, we determined the ability of AMPKα2 to phosphory-
late a recombinant HIF-1α peptide (corresponding to amino acids 
1–735) in vitro. We found that AMPKα2 was able to elicit the 
serine but not the threonine phosphorylation of HIF-1α (Online 
Figure VII); however, we were unable to confirm the AMPK-
mediated phosphorylation of HIF-1α in isolated neutrophils.
HIF-1α protein levels are barely detectable in normoxic 
conditions largely because of the high activity of the prolyl 
hydroxylase domain (PHD)–containing enzymes, which hy-
droxylate HIF-1α (on Pro564) thus promoting its subsequent 
proteasome-mediated degradation.24 In response to hypoxia, 
PHD enzymes and the degradation of HIF-1α are inhibited. 
Interestingly, the downregulation of AMPKα2 enhanced the 
hydroxylation of HIF-1α on proline 564 in cells exposed to 
hypoxia, indicating that the effect of AMPKα2 on HIF-1α may 
be indirectly regulated via PHD activity. Indeed, treatment 
with the PHD inhibitor dimethyloxalylglycine restored HIF-
1α levels in cells treated with AMPKα2 siRNA (Figure 6C). 
This implies that AMPKα2 regulates HIF-1α stabilization un-
der hypoxia by interfering with its hydroxylation and thereby 
inhibiting its proteasomal degradation. Consistent with the 
observed effects on HIF-1α destabilization, the expression of 
the hypoxia-regulated genes, VEGF and stromal cell–derived 
factor-1, was decreased in lipopolysaccharide-stimulated neu-
trophils from AMPKα2ΔMC mice (Figure 7A). In the same cells, 
the expression of the proinflammatory markers, tumor necro-
sis factor-α and IL-1β, was increased (Figure 7B) and fit well 
with the altered cytokine and growth factor expression profile 
detected in the ischemic muscles (Figure 3C). Neutrophil re-
cruitment to ischemic tissues involves several secreted factors 
including cathelicidin-related antimicrobial peptide (LL-37 in 
humans) and CD147 (basigin), both of which were increased 
in hypoxic neutrophils from wild-type mice but not in those 
lacking the α2 subunit (Figure 7C and 7D).
AMPKα2 Regulates HIF-1α Hydroxylation by 
Modulating α-Ketoglutarate Levels
Because HIF-1α also regulates the cellular metabolic state, we 
analyzed metabolic parameters in isolated neutrophils. Under 
normoxic conditions, the deletion of AMPKα2 in neutrophils 
was associated with increased oxygen consumption, both in 
the absence of stimulation and when maximally stimulated 
with FCCP (Figure 7F; Online Figure VIIIA through VIIIE). 
The latter fits well with an increased phorbol ester–induced 
generation of reactive oxygen species (Figure 7G). There was 
no difference in glycolysis in neutrophils from the 2 strains 
under the conditions studied (Online Figure VIIIF). Hypoxia 
is a potent activator of AMPK, and because the Seahorse 
analyses could not be performed under hypoxic conditions, 
mass spectrometry was used to assess metabolic alterations in 
hypoxic neutrophils. Consistent with the extracellular acidifi-
cation data, there were no detectable differences in glucose or 
lactate levels between the 2 strains of neutrophils maintained 
in normoxic or hypoxic conditions (Online Figure VIIIG 
through VIIIJ).
Proteomic analysis revealed a significant, hypoxia-induced 
decrease in 2 isoforms of the isocitrate dehydrogenase (IDH), 
that is, cytosolic IDH1 and mitochondrial IDH3b (Figure 8A 
and 8B). In the same cells, metabolomic analyses revealed 
Figure 4. Myeloid cell infiltration 
into the ischemic hindlimb 24 h post 
surgery. A and B, CD45+ and Gr1+ cells 
isolated from the gastrocnemius muscle 
of the ligated and nonligated hindlimbs 
from wild-type (WT) and AMPKα2ΔMC 
(ΔMC) mice 24 h after ligation (n=6 per 
group). C, In vitro stromal cell–derived 
factor-1–induced transendothelial 
migration of bone marrow–derived 
neutrophils from WT and AMPKα2ΔMC 
mice (n=4–6 per group). D, Ly6G+ 
and CRAMP+ neutrophils in ischemic 
semimembranosus muscles from WT and 
ΔMC mice 1 d post surgery. The images 
are representative of data obtained in an 
additional 3 animals per group. Upper: 
bar=200 µm; lower: bar=10 µm. *P<0.05, 
**P<0.01, ***P<0.001 vs WT. AMPK 
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that although the IDH product α-ketoglutarate decreased in 
wild-type neutrophils exposed to hypoxia, it failed to do so 
in hypoxic neutrophils from AMPKα2ΔMC mice (Figure 8C). 
α-Ketoglutarate is required as a cofactor for PHD enzymes 
and the subsequent hydroxylation of HIF-1α. The hypoxia-
induced decrease in α-ketoglutarate production prevents the 
hydroxylation and degradation of HIF thus facilitating the 
induction of HIF-1α–regulated genes. Certainly, incubating 
human leukemic monocyte THP-1 cell line with octyl-α-
ketoglutarate, a cell-permeable ester of α-ketoglutarate, was 
sufficient to abrogate HIF-1α expression in cells exposed to 
hypoxia (Figure 8D).
Discussion
The results of the present study indicate that the AMPKα2 sub-
unit is important in determining neutrophil survival and function 
in ischemic tissue. The mechanisms involved are related to the 
stabilization of HIF-1α protein by preventing its hydroxylation 
under hypoxia and the expression of a network of proteins—
many of which affect mitochondrial function and cell survival. 
In the absence of these mechanisms, neutrophil survival is at-
tenuated, and the recruitment of proangiogenic monocytes to 
ischemic areas is reduced, thus impairing the processes of arte-
riogenesis and angiogenesis (Online Figure IX).
Limb ischemia as a consequence of vascular injury initiates 
a series of events that involve an inflammatory phase, charac-
terized by cell infiltration and the initiation of angiogenesis, 
followed by a resolution phase. The processes involved are com-
plex, but many pharmaceutical tools, such as metformin, have 
been reported to improve vascular repair, at least in wild-type 
mice.25 One key signaling event that is altered in diabetes mel-
litus and targeted by metformin is the activation of the AMPK.26 
To determine the importance of the AMPK in vascular repair, 
the recovery of blood flow after ischemia was assessed in wild-
type and AMPKα-deficient mice. The focus of the studies was 
the AMPKα2 subunit, given its reported link to diabetes melli-
tus14 and its activation by hypoxia.21 We found that the recovery 
of blood flow was significantly impaired in ischemic hindlimbs 
from animals completely deficient in the AMPKα2 subunit. 
Interestingly, targeting AMPKα2 in endothelial cells did not im-
pair vascular repair, whereas its deletion in myeloid cells repro-
duced the effects observed in the AMPKα2−/− mice. Certainly, the 
AMPKα2 isoform was clearly expressed in CD11b+ cells, and 
in animals lacking AMPKα2 in the myeloid linage (AMPKα2ΔMC 
mice), arteriogenesis and angiogenesis in the ischemic hindlimb 
were substantially reduced. The myeloid cell–specific deletion 
of the AMPKα1 subunit also delayed the recovery of blood flow 
after femoral artery ligation, but the defect was much less pro-
nounced than that in the AMPKα2ΔMC mice. Although in our 
study the role of AMPKα2 deletion in neutrophils was more 
pronounced, it is possible that the AMPKα1 isoform plays a sig-
nificant role in the regulation of monocyte function as described 
in an article published during the revision of this article.27
Consistent with a previous report that the deletion of the 
AMPK had no effect on normal hematopoietic stem cell dif-
ferentiation or function,17 the myeloid cell–specific deletion of 
the AMPKα2 was without effect on hematopoietic stem cell 
differentiation. Interestingly, circulating levels of neutrophils 
were attenuated by the deletion of the AMPKα2 under basal 
conditions but were comparable in wild-type and AMPKα2ΔMC 
mice 24 hours after femoral artery ligation indicating normal 
neutrophil generation and mobilization.
Although neutrophils are early infiltrating cells that control 
critical steps during angiogenesis, collateral growth, and per-
fusion recovery, they have a short half-life within the ischemic 
tissue.28,29 Comparing the numbers of neutrophils that infiltrat-
ed ischemic skeletal muscle 1 and 3 days after femoral artery 
ligation revealed that despite increased neutrophil infiltration 
in ischemic AMPKα2ΔMC hindlimbs after 24 hours, the situa-
tion was reversed after 72 hours. These observations indicated 
that neutrophil survival was attenuated in the absence of the 
Figure 5. Effect of AMP-activated protein kinase (AMPK) α2 
deletion on neutrophil apoptosis. Neutrophils from wild-type (WT) 
and AMPKα2ΔMC (ΔMC) littermates were incubated under normoxic 
(Nox) or hypoxic (Hox) conditions for 16 h (n=6 per group). A, 
Translocase of inner mitochondrial membrane 50 (TIM50) label-free 
quantification (LFQ) intensity (left) and Western blot of neutrophils 
maintained under hypoxic conditions (right). B, Api5 LFQ intensity 
(left) and Western blot of neutrophils maintained under hypoxic 
conditions (right). C, Expression of cleaved caspase-3 (Cl. Casp. 
3) and Bax in bone marrow–derived neutrophils from wild-type 
(WT) and AMPKα2ΔMC (ΔMC) littermates (n=8 per group for Cl. 
Casp. 3 and n=5 per group for Bax expression). D, Caspase-3/7 
activity measured as DEVD (7-amino-4-trifluoromethyl coumarin)  
fluorescence after cleavage from Asp-Glu-Val-Asp in neutrophils 
from WT and ΔMC littermates (n=5 per group). Cells were 
incubated with solvent or the caspase inhibitor (Z-VAD-FMK, 10 
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AMPKα2 subunit. Certainly, AMPK activation has previously 
been linked with neutrophil survival,30 and in this study, apop-
tosis was increased in AMPKα2-deficient neutrophils. Some 
of the proteins significantly altered in hypoxic AMPKα2ΔMC 
versus wild-type neutrophils were linked to apoptosis, in 
particular translocase of inner mitochondrial membrane 
50, a component of the mitochondrial translocator,31 and 
apoptosis inhibitor 5, a negative regulator of E2F1-dependent 
cell death.32 Little is known about the role played by either 
protein in neutrophils, but the loss of translocase of inner mi-
tochondrial membrane 50 has also been reported to increase 
apoptosis in breast cancer cells.33
Part of the arteriogenic/angiogenic response can be at-
tributed to the liberation of neutrophil-derived VEGF, matrix 
Figure 6. Link between AMP-activated 
protein kinase (AMPK) α2 and hypoxia-
inducible factor-1α (HIF-1α). A, Pie 
charts depicting significantly regulated 
proteins in neutrophils from wild-type 
(WT) and AMPKα2ΔMC (ΔMC) mice after 
16-h exposure to hypoxia. Upper: total 
number of significantly regulated proteins. 
Lower: number of significantly up- and 
downregulated proteins. B, HIF-1α levels 
in HEK293 cells transfected with a control 
siRNA (CTL) or siRNA directed against 
AMPKα1 (siα1) or AMPKα2 (siα2) and 
then either maintained under normoxic 
conditions, exposed to hypoxia (1% O2, 
6 h) or stimulated with CoCl2 (150 µmol/L, 
6 h). Graphs summarize data from 5 
independent experiments. C, HEK293 cells 
transfected with a control siRNA (siCTL) 
or siRNA-directed against AMPKα2 (siα2) 
were exposed to hypoxia in the presence 
of solvent (Solv) or dimethyloxalylglycine 
(DMOG; 1 mmol/L) for 16 h. HIF-1α levels 
and its hydroxylation on proline 564 (OH-
P564) were analyzed by Western blotting 
(n=9–12 per group). The break in the blots 
indicates that nonadjacent lanes in the 
same Western blot are presented. *P<0.05, 
**P<0.01, ***P<0.001.
Figure 7. Hypoxic response in neutrophils 
and mitochondrial metabolism. A and 
B, Bone marrow neutrophils were isolated 
from wild-type (WT) and AMPKα2ΔMC 
(ΔMC) littermates, and the expression of 
the angiogenic (VEGF and stromal cell–
derived factor-1 [SDF-1]) and inflammatory 
markers (tumor necrosis factor [TNF]-α and 
interleukin [IL]-1β) were analyzed. The graphs 
summarize data from 8 to 9 individual 
animals in each group from 3 independent 
experiments. C and D, Neutrophils from WT 
and ΔMC littermates were incubated under 
normoxic (Nox) or hypoxic (Hox) conditions 
for 16 h (n=6 per group). C, cathelicidin-
related antimicrobial peptide (CRAMP) 
protein expression (label-free quantification 
[LFQ] intensity). D, CD147 protein levels 
(LFQ intensity) and immunohistochemistry, 
CD147 (red), and phalloidin (green). Bar=10 
µm. E, Matrix metalloproteinase (MMP)-
9 mRNA expression (n=4 per group). F, 
Oxygen consumption rate (OCR) profile 
as an index of mitochondrial respiration 
in bone marrow–derived neutrophils 
from WT and ΔMC mice. G, DCHF 
(2′-7′-dichlorofluorescin) fluorescence in 
bone marrow–derived neutrophils from WT 
and ΔMC mice treated with solvent (Sol) 
or PMA (phorbol 12-myristate 13-acetate; 
100 ng/mL) for 20 min (n=7–8 per group). 
*P<0.05, **P<0.01, ***P<0.001. AMPK 
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metalloproteinases, and other proangiogenic growth factors,34 
but these cells also release factors such as cathelicidins that 
promote the recruitment of monocytes,35,36 which then amplify 
the angiogenic and arteriogenic processes. Thus, the observed 
decrease in monocyte recruitment to the ischemic tissue 72 
hours after ligation is likely to be linked to neutrophil loss. The 
same mechanism likely underlies the decreased expression of 
proangiogenic factors in hindlimbs from AMPKα2ΔMC mice. 
How can the increase in neutrophil infiltration at 24 hours be 
accounted for? This may be related a combination of enhanced 
neutrophil migratory activity and crosstalk between the neu-
trophils and the vasculature. Certainly, the expression of ad-
hesion molecules such as intercellular adhesion molecule-1 
was increased in hindlimbs from AMPKα2ΔMC mice, hinting 
that endothelial cell activation was enhanced. This is a neutro-
phil-dependent effect as endothelial cells from wild-type and 
AMPKα2ΔMC mice responded to IL-1β and lipopolysaccharide 
stimulation with similar increases in adhesion molecule ex-
pression (R. Abdel Malik et al, unpublished data, 2016).
The inhibition of neutrophil apoptosis in a hypoxic environ-
ment is dependent on the activation of HIF-1α,19 and interac-
tions between HIF-1α and AMPK have been reported. Indeed, 
increased AMPKα expression and activity are paralleled by 
the upregulation of HIF-1α in cancer cells,37 and the inhibition 
of AMPK was found to impair the nuclear accumulation of 
HIF-1α under hypoxia or low glucose conditions.38 We found 
that the downregulation of the AMPKα2 but not the AMPKα1 
subunit attenuated the increase in HIF-1α levels induced by ei-
ther hypoxia or cobalt chloride. In agreement with our in vitro 
observations, the expression of the HIF-1α–regulated factors, 
stromal cell–derived factor-1 and VEGF, was attenuated in 
neutrophils from AMPKα2ΔMC mice. AMPK has also been pro-
posed to regulate HIF-1α protein stability by phosphorylation.23 
However, even though we could confirm these findings in an in 
vitro assay, we were unable to detect an AMPKα2-dependent 
phosphorylation of HIF-1α in intact cells. Instead, it was pos-
sible to demonstrate that the deletion of the AMPKα2 subunit 
enhanced the hydroxylation of HIF-1α on Pro564 in cells ex-
posed to hypoxia. The latter response is indicative of increased 
PHD activity and proteasomal degradation. Indeed, treating 
AMPKα2-deficient neutrophils with a PHD inhibitor prevented 
the enhanced hydroxylation and rescued HIF-1α induction.
Unlike the AMPKα1 subunit, the AMPKα2 can translocate 
to the nucleus and affect gene and protein expression by several 
mechanisms.1 Mass spectrometry was used to ascertain which 
neutrophil proteins could be affected by AMPKα2 deletion and 
revealed that although wild-type neutrophils exposed to hypoxia 
increased expression of the granule protein cathelicidin-related 
antimicrobial peptide (LL-37 in humans) and CD147 (basigin 
or extracellular matrix metalloproteinase inducer), effects were 
blunted in AMPKα2ΔMC neutrophils. The latter proteins were 
of interest as both are regulated by HIF-1α39,40 and both are in-
volved in neutrophil recruitment, invasion, and survival in isch-
emic tissues.35,41–43 Of interest for vascular repair is that CD147 
is reportedly required for the increased synthesis of VEGF and 
matrix metalloproteinase-944,45; thus, the lower levels of matrix 
metalloproteinase-9 in the AMPKα2ΔMC neutrophils may be re-
lated to their failure to increase CD147 expression.
Prolyl hydroxylases require oxygen and the electron donor 
α-ketoglutarate to execute the hydroxylation and inactivation of 
HIF-1α.46 Neutrophil adaption to hypoxia and the stabilization 
of HIF-1α, therefore, require accompanying changes in metab-
olism and a decrease in α-ketoglutarate production. Isocitrate 
dehydrogenases catalyze the oxidative decarboxylation of isoci-
trate to α-ketoglutarate, and 2 IDH isoforms, that is, IDH1 and 
IDH3b, were differentially regulated by hypoxia in neutrophils 
from wild-type and AMPKα2ΔMC mice. Specifically, the decrease 
in IDH expression detected in wild-type neutrophils exposed to 
Figure 8. AMP-activated protein kinase 
(AMPK) regulates levels of isocitrate 
dehydrogenases and α-ketoglutarate. 
Neutrophils from wild-type (WT) and 
AMPKα2ΔMC (ΔMC) littermates were 
incubated under normoxic (Nox) or 
hypoxic (Hox) conditions for 16 h (n=6 
per group). A, Isocitrate dehydrogenase 
(IDH) 1 and IDH3b expression (label-
free quantification intensity). B, Western 
blot confirmation of altered IDH1 and 
IDH3b expression. C, α-Ketoglutarate 
(α-KG) levels in neutrophils from WT and 
ΔMC littermates incubated under Nox 
or Hox conditions for 16 h (n=5–6 per 
group). D, HIF-1α levels in THP-1 cells 
incubated in Hox conditions for 6 h with 
indicated concentrations of octyl-α-KG, 
a cell-permeable ester of α-KG (n=6 
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hypoxia failed to occur in AMPKα2-deficient neutrophils. The 
changes in IDH expression were reflected in α-ketoglutarate lev-
els, which were decreased by hypoxia in wild-type neutrophils 
but remained elevated in neutrophils from AMPKα2ΔMC mice. It 
is interesting to note that higher IDH1 levels have been linked 
with increased HIF-1α degradation and the sensitization of mela-
noma cells to hypoxia-induced apoptosis,47 effects that parallel 
the fate of AMPKα2-deficient neutrophils. Moreover, inhibition 
of IDH by oxalomalic acid or IDH knockdown was reported to 
elevate HIF-1α levels.48 It, therefore, seems that the links between 
AMPKα2 and HIF-1α are complex and may be regulated at more 
levels than the direct phosphorylation of the transcription factor.
Taken together, these observations indicate that the acti-
vation of AMPKα2 in neutrophils is a decisive event in the 
initiation of vascular repair after ischemia. It is tempting to 
speculate that dysregulation of AMPK signaling, such as is 
the case in diabetes mellitus, may attenuate vascular repair 
by a combination of effects on HIF-1α stability mediated by 
alterations in phosphorylation and myeloid cell metabolism.
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What Is Known?
• Myeloid cells are rapidly recruited to ischemic tissue and are required 
for the initiation of vascular repair.
• Neutrophils are the first cell population to infiltrate ischemic tissue and 
secrete factors that recruit a second wave of monocytes.
• Neutrophils are short lived, but their half-life is prolonged in ischemic 
tissue by increased expression of the hypoxia-inducible factor (HIF)-1α.
• HIF-1α protein levels are barely detectable in normoxic conditions be-
cause of the high activity of the prolyl hydroxylase domain–containing 
enzymes that hydroxylate HIF-1α and promote its degradation.
What New Information Does This Article Contribute?
• Global deletion of the AMP-activated protein kinase (AMPKα2) subunit 
or its specific deletion in myeloid cells abrogate arteriogenesis and 
angiogenesis and prevents the recovery of hindlimb blood flow after 
femoral artery ligation.
• Activation of the AMPKα2 subunit in neutrophils is essential for their sur-
vival in the ischemic hindlimb and subsequent monocyte recruitment.
• In the absence of AMPKα2, the changes in neutrophil protein expres-
sion elicited by hypoxia are attenuated, a phenomenon attributed to the 
failure to stabilize HIF-1α protein expression.
• In hypoxic conditions, AMPKα2 activation leads to a decrease in the 
expression of 2 isoforms of the isocitrate dehydrogenase and the gen-
eration of α-ketoglutarate, which is required as a cofactor for prolyl hy-
droxylase domain enzymes and the subsequent HIF-1α hydroxylation.
Limb ischemia, as a consequence of vascular injury, initiates a se-
ries of events that involve an inflammatory phase, characterized 
by cell infiltration and the initiation of angiogenesis, followed by a 
resolution phase. Neutrophils are early infiltrating cells that liber-
ate several key factors that promote the subsequent recruitment 
of monocytes, which then amplify the arteriogenic and angiogen-
ic processes. This study shows that the activation of AMPKα2 in 
neutrophils is required for arteriogenesis and angiogenesis in the 
ischemic hindlimb. In its absence, neutrophils fail to survive to 
recruit monocytes to the ischemic region, and as a consequence, 
the ischemic area is maintained in an inflammatory rather than 
an arteriogenic/angiogenic state. A combination of proteomic 
and metabolomic analyses show that AMPKα2 determines the 
response of neutrophils in an ischemic environment, partly by 
decreasing isocitrate dehydrogenase expression. The latter step 
is essential to decrease cellular levels of α-ketoglutarate and 
prevent the hydroxylation and degradation of HIF-1α. Diabetes 
mellitus is not only a risk factor for the development of cardio-
vascular disease but is linked with impaired vascular repair after 
injury and ischemia. Given that AMPK activity is dysregulated in 
diabetes mellitus, the rapid application of AMPK activators may 
promote vascular repair in diabetic individuals by a combination 
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